Q4 2020 Holdings
Filed 2021-02-12 | 200 holdings | $321.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $66.4M | 619,759 | 20.7% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $60.4M | 246,844 | 18.8% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $24.4M | 278,330 | 7.6% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $22.7M | 174,894 | 7.1% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $18.1M | 61,687 | 5.6% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $17.7M | 331,789 | 5.5% |
| Adaptive Biotechnologies Corporation(ADPT) | Common | 00650F109 | $16.9M | 286,013 | 5.3% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $16.1M | 96,246 | 5.0% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $10.2M | 132,886 | 3.2% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $8.8M | 246,089 | 2.8% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $7.3M | 28,280 | 2.3% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $7.0M | 28,154 | 2.2% |
| Arvinas, Inc.(ARVN) | Common | 04335A105 | $6.2M | 73,459 | 1.9% |
| Cogent Biosciences, Inc.(COGT) | Common | 19240Q201 | $6.0M | 537,742 | 1.9% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $5.4M | 10,041 | 1.7% |
| Centene Corporation(CNC) | Common | 15135B101 | $5.1M | 84,145 | 1.6% |
| Addus HomeCare Corporation(ADUS) | Common | 006739106 | $4.4M | 37,640 | 1.4% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $4.2M | 300,611 | 1.3% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $3.9M | 607,698 | 1.2% |
| Axsome Therapeutics, Inc.(AXSM) | Common | 05464T104 | $2.6M | 31,591 | 0.8% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $2.1M | 101,412 | 0.7% |
| Allogene Therapeutics, Inc.(ALLO) | Common | 019770106 | $1.2M | 48,089 | 0.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $875.0K | 117,735 | 0.3% |
| Cellectis(CLLS) | Sponsored ADR | 15117K103 | $324.0K | 11,955 | 0.1% |
| Celldex Therapeutics, Inc.(CLDX) | Common | 15117B202 | $124.0K | 7,053 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $95.8K | 416,560 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $95.3K | 257,493 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $86.7K | 179,385 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $86.1K | 546,805 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $81.9K | 1,405,371 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $78.4K | 501,942 | 0.0% |
| Unitedhealth Group Incorporated(UNH) | Common | 91324P102 | $76.9K | 219,185 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $72.2K | 305,310 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $62.7K | 534,914 | 0.0% |
| Bristol Myers Squibb Company(BMY) | Common | 110122108 | $61.4K | 989,908 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $59.4K | 127,553 | 0.0% |
| Seagen Inc.(SGENUSD) | Common | 81181C104 | $51.4K | 293,619 | 0.0% |
| Danaher Corporation(DHR) | Common | 235851102 | $48.8K | 219,840 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $47.2K | 431,145 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $45.9K | 560,903 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $40.1K | 237,537 | 0.0% |
| Stryker Corporation(SYK) | Common | 863667101 | $37.6K | 153,330 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $35.2K | 206,487 | 0.0% |
| Horizon Therapeutics plc | Shares | G46188101 | $34.0K | 465,016 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $34.0K | 82,807 | 0.0% |
| Zimmer Biomet Holdings, Inc.(ZBH) | Common | 98956P102 | $33.0K | 214,014 | 0.0% |
| Becton, Dickinson and Company(BDX) | Common | 075887109 | $33.0K | 131,723 | 0.0% |
| HCA Healthcare, Inc.(HCA) | Common | 40412C101 | $28.8K | 175,097 | 0.0% |
| Cigna Corporation(CI) | Common | 125523100 | $28.3K | 135,712 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $28.2K | 294,234 | 0.0% |